Hong Kong Researchers Developing Affordable Blood Test for Prostate Cancer
Quick Look
- Hong Kong researchers are developing an affordable blood test for prostate cancer, aiming to reduce the need for invasive biopsies.
- The technology is expected to launch in about two years, offering a less uncomfortable diagnostic process for patients like Peter Wan, who experienced a lengthy and invasive journey to his diagnosis.
AI-generated summary
Why It Matters
Peter Wan Ying-keung, a retired Hong Kong businessman, recalls the difficult months-long journey to his prostate cancer diagnosis 13 years ago, which involved an invasive biopsy. Local researchers are developing a less invasive and affordable blood test.
Retired Hong Kong businessman Peter Wan Ying-keung still remembers the uncertainty and discomfort of his months-long journey to a prostate cancer diagnosis 13 years ago.
It began with a routine blood test in 2013 that showed elevated levels of prostate-specific antigen (PSA), a possible warning sign of cancer.
Wan, now 73, then underwent an invasive biopsy to extract tissue samples from his prostate – a procedure that left him bleeding for around two days. From the initial test to a confirmed diagnosis, the process took three months.
“The biopsy procedure could be frightening for some people,” Wan said. “It would be ideal if a diagnosis could be made without a biopsy.”
Local researchers have said that they hope fewer patients in Hong Kong will need to undergo invasive biopsies to confirm cancer, as they are developing an affordable blood test to screen for the disease, with plans to launch the technology in about two years.
What to Watch
AI outlook — possibilities, not facts
New prostate cancer blood test technology to launch in Hong Kong.
Likely · Within months
Open Questions
- What is the specific accuracy rate of the new blood test?
- What will be the exact cost of the new blood test?
- Which specific institutions are developing this technology?
